By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California made a bold announcement that it would manufacture a state-branded, low-cost insulin. It still is not here.
China, India and the US will have the world’s largest populations of adults living with overweight and obesity by 2050, ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
Brands That Matter panel to examine Purdue-led pharmaceutical transformations ...
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
People who land in the ER after using hallucinogens are more than twice as likely to die in a handful of years, a new study ...
The lifetime risk of dementia after age 55 is about 42%, according to a recent study published in the journal Nature Medicine. Around 1 million adults in the U.S. are projected to develop dementia ...
Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback